Institutional investors hold a majority ownership of ZTS through the 96.40% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2015, these large investors purchased a net $14.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WINSLOW CAPITAL MANAGEMENT LLC Bought 4.8 Million shares of Zoetis Inc
NEUBERGER BERMAN LLC Bought 2.5 Million shares of Zoetis Inc
CANTILLON CAPITAL MANAGEMENT LLC Bought 2.3 Million shares of Zoetis Inc